11/25/2024
7:35 AM | Immunome (Issuer)
Lechleider Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
7:41 AM | Immunome (Issuer)
SIEGALL CLAY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
7:33 AM | Immunome (Issuer)
Tsai Philip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | Immunome (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
9:33 AM | Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
11/13/2024
3:06 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
2:57 PM | Immunome (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
|
11/04/2024
10:54 AM | Immunome (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/29/2024
7:05 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Immunome (Subject)
| Form SC 13G | |
10/08/2024
3:31 PM | Immunome (Filer)
| Form S-3ASR | |
10/07/2024
6:14 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
6:26 PM | Immunome (Issuer)
Rosett Max (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
1:18 PM | Immunome (Subject)
Rosett Max (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
8:05 PM | Higgins Jack (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
8:07 PM | BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
2:21 PM | Higgins Jack (Reporting)
Immunome (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
4:48 PM | Immunome (Issuer)
Turner Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:51 PM | Horn Kinney (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:54 PM | Immunome (Issuer)
Stoneman Sandra G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:56 PM | Immunome (Issuer)
SIEGALL CLAY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:36 PM | Higgins Jack (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:40 PM | Immunome (Issuer)
Lechleider Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:43 PM | Immunome (Issuer)
Rosett Max (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:10 PM | Immunome (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/18/2024
7:52 PM | BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:54 PM | Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:56 PM | Immunome (Issuer)
SWAIN SANDRA M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:59 PM | Immunome (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:01 PM | Boylan James P (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:05 PM | Immunome (Issuer)
Tsai Philip (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2024
8:08 PM | Immunome (Issuer)
Tsai Philip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:48 PM | Barchas Isaac (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:05 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
3:49 PM | BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:13 PM | Immunome (Issuer)
SIEGALL CLAY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:11 PM | Immunome (Issuer)
Rosett Max (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
7:48 AM | Immunome (Filer)
| Form 424B5 | |
05/14/2024
7:05 AM | Immunome (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
7:02 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
7:14 PM | Immunome (Issuer)
SWAIN SANDRA M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This company will win the AI race (Ad) Rome wasn’t built in a day…
But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence.
And without it, the entire AI industry would collapse.  You must read this new presentation from Porter Stansberry. |
04/29/2024
7:12 PM | Immunome (Issuer)
SWAIN SANDRA M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/26/2024
3:12 PM | Immunome (Filer)
| Form ARS | |
04/25/2024
3:01 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
3:40 PM | Immunome (Filer)
| Form S-3ASR | |
03/28/2024
3:04 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:06 PM | Immunome (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
7:05 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
8:07 PM | Horn Kinney (Reporting)
Immunome (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/21/2024
8:10 PM | Horn Kinney (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
1:10 PM | Alpine Global Management, LLC (Filed by)
Immunome (Subject)
| Form SC 13G/A | |
02/06/2024
7:05 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
8:18 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
7:50 PM | Immunome (Issuer)
Stoneman Sandra G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
7:53 PM | Immunome (Issuer)
Rosett Max (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:27 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:05 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
4:33 PM | Immunome (Issuer)
SCHAFER CAROL (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/04/2024
4:37 PM | Immunome (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:40 PM | Immunome (Issuer)
Lapetina Bob (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:05 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:00 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
7:35 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
6:24 PM | Immunome (Issuer)
Roberts Phil Noland (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/15/2023
6:28 PM | Immunome (Issuer)
Roberts Phil Noland (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
8:08 PM | Higgins Jack (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
